BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6897732)

  • 21. Intrathecal dacarbazine treatment of leptomeningeal malignant melanoma.
    Champagne MA; Silver HK
    J Natl Cancer Inst; 1992 Aug; 84(15):1203-4. PubMed ID: 1635089
    [No Abstract]   [Full Text] [Related]  

  • 22. Intrathecal liposomal cytarabine and leptomeningeal medulloblastoma relapse: a valuable therapeutic option.
    Mastronuzzi A; Del Bufalo F; Iacono A; Secco DE; Serra A; Colafati GS; DE Ioris MA; Corsetti T
    Anticancer Res; 2013 Aug; 33(8):3515-8. PubMed ID: 23898128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Carcinoma of the colon associated with diffuse metastatic leptomeningeal carcinomatosis (DMLC) presenting as disturbance of consciousness--a case report].
    Ohkawa H; Nakazawa K; Nakada K; Miyauchi J
    Gan No Rinsho; 1984 Apr; 30(4):409-12. PubMed ID: 6727042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.
    Glantz MJ; Jaeckle KA; Chamberlain MC; Phuphanich S; Recht L; Swinnen LJ; Maria B; LaFollette S; Schumann GB; Cole BF; Howell SB
    Clin Cancer Res; 1999 Nov; 5(11):3394-402. PubMed ID: 10589750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leptomeningeal carcinomatosis: review of the literature.
    Iaconetta G; Lamaida E; Rossi A; Signorelli F; Manto A; Giamundo A
    Acta Neurol (Napoli); 1994 Aug; 16(4):214-20. PubMed ID: 7856476
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone.
    Kim DY; Lee KW; Yun T; Park SR; Jung JY; Kim DW; Kim TY; Heo DS; Bang YJ; Kim NK
    Jpn J Clin Oncol; 2003 Dec; 33(12):608-12. PubMed ID: 14769837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A diffuse metastatic leptomeningeal carcinomatosis from gallbladder cancer; case report].
    Takeuchi T; Ogawa H; Kasahara E; Sakurada M; Satoh S
    No Shinkei Geka; 1991 Nov; 19(11):1091-5. PubMed ID: 1762661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrathecal depot cytarabine therapy: a welcome addition to a limited armamentarium.
    Bleyer WA
    Clin Cancer Res; 1999 Nov; 5(11):3349-51. PubMed ID: 10589743
    [No Abstract]   [Full Text] [Related]  

  • 29. Intrathecal 4-hydroperoxycyclophosphamide: neurotoxicity, cerebrospinal fluid pharmacokinetics, and antitumor activity in a rabbit model of VX2 leptomeningeal carcinomatosis.
    Phillips PC; Than TT; Cork LC; Hilton J; Carson BS; Colvin OM; Grochow LB
    Cancer Res; 1992 Nov; 52(22):6168-74. PubMed ID: 1423260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.
    Orlando L; Curigliano G; Colleoni M; Fazio N; Nole F; Martinelli G; Cinieri S; Graffeo R; Peruzzotti G; Goldhirsch A
    Anticancer Res; 2002; 22(5):3057-9. PubMed ID: 12530042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosing leptomeningeal carcinomatosis with negative CSF cytology in advanced prostate cancer.
    Bernstein WB; Kemp JD; Kim GS; Johnson VV
    J Clin Oncol; 2008 Jul; 26(19):3281-4. PubMed ID: 18591564
    [No Abstract]   [Full Text] [Related]  

  • 32. [Leptomeningeal carcinomatosis as the primary manifestation of a gastric carcinoma].
    Martínez Gil A; Marti Cabane J; Arrinda JM; Bustillo JM
    An Med Interna; 1990 Jun; 7(6):330-1. PubMed ID: 2102745
    [No Abstract]   [Full Text] [Related]  

  • 33. Leptomeningeal carcinomatosis. How does cancer reach the pia-arachnoid?
    Kokkoris CP
    Cancer; 1983 Jan; 51(1):154-60. PubMed ID: 6336971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Metastatic carcinomatosis of the dura mater of the brain].
    Taĭtslin VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(5):657-63. PubMed ID: 6880488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of intrathecal trastuzumab in a patient with carcinomatous meningitis.
    Laufman LR; Forsthoefel KF
    Clin Breast Cancer; 2001 Oct; 2(3):235. PubMed ID: 11899418
    [No Abstract]   [Full Text] [Related]  

  • 36. [Meningeal carcinomatosis in gastric cancer].
    Vedrine L; Artru P; Tournigand C; Louvet C; De Gramont A; Krulik M
    Gastroenterol Clin Biol; 2001 Apr; 25(4):422-4. PubMed ID: 11449130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progressive blindness caused by metastatic occult signet-ring cell gastric carcinoma.
    McCrary JA; Patrinely JR; Font RL
    Arch Ophthalmol; 1986 Mar; 104(3):410-3. PubMed ID: 3006649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of adult patients receiving intraventricular chemotherapy for the treatment of leptomeningeal metastasis.
    Aiello-Laws L; Rutledge DN
    Clin J Oncol Nurs; 2008 Jun; 12(3):429-35. PubMed ID: 18515241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Meningeal carcinomatosis in cancer patients].
    Danova M; Invernizzi R
    Tumori; 2005; 91(5):10-21. PubMed ID: 16459648
    [No Abstract]   [Full Text] [Related]  

  • 40. [Extraordinary manifestation of a gastric carcinoma by leptomeningeal carcinomatosis and spinal metastasis].
    Cresto N; Barth A; Arnold M; Weimann R; Gschossmann J; Ochsenbein AF; Kolotas C; Peter HJ; Schiemann U
    Med Klin (Munich); 2007 Mar; 102(3):255-8. PubMed ID: 17345022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.